Barely Significant
← all phrases

“did not reach statistical significance”

111,028 sentences · 111,028 papers · 130,054 search hits before verification

In the literature

It was also noted that the changes in several ABPM indicators of the ALI/AML group did not reach statistical significance compared to the AML group (except for changes in the daytime DBP between the two treatment groups, p = 0.0309).
In the present study, the effects of upper- and lower-body exercise trials on fat oxidation rates on day 2 were comparable, although differences between the lower-body exercise and control trials did not reach statistical significance (upper-body exercise trial: ES = 0.459, 95%CI 0.00 to 0.03, P = 0.031; lower-body exercise trial: ES = 0.436, 95%CI –0.03 to 0.00, P = 0.061).
Increased inflammatory parameters, such as CRP and WBC count, tended to be associated with smaller sEVs (modal diameter), but the association did not reach statistical significance for WBC count (ρ = −0.376, p = 0.031 for CRP levels; ρ = −0.342, p = 0.051 for WBC count).
For mBI, although the Friedman test indicated a significant temporal trend in the G-FMV group, post hoc pairwise comparisons did not reach statistical significance after Bonferroni correction (T0–T1: p = 0.031; T0–T2: p = 0.035; threshold p < 0.025).
Although the anteroposterior thoracic diameter did not reach statistical significance in multivariate analysis, it still showed a similar trend for PPCs in univariate analysis (OR = 1.763, 95% CI: 1.050–2.961, p = 0.032), possibly due to a limited sample size.
Although differences in AUC between Swin-T and ResNet34, InceptionV3, and ResNet152 did not reach statistical significance, McNemar’s test indicated Swin-T produced significantly fewer classification errors compared to ResNet34 ( p = 0.0328) and InceptionV3 ( p = 0.0304), suggesting a consistent advantage in practical diagnostic performance ( Table 3 ).
μ static , Tps=120s ( Figure 3A ) at t = 0 d averaged 0.094 ± 0.008, and relative to that, at t = 10 d for F + MSC tended to increase (+37%), but did not reach statistical significance ( P = .033, α = .05/3). μ kinetic ( Figure 3B ) at t = 0 d averaged 0.024, and relative to that value, increased (+94%) at t = 10 d for fibrin and F + MSC treatments (each, P < .01).
Although CHA2DS2-VASc score categories did not reach statistical significance, a 1-point increase in the score was associated with a lower probability of favorable outcomes at 1 month (OR = 0.73, 95% CI 0.55–0.97, p < 0.033).
Nevertheless, all these groups did not reach statistical significance except for the changes in CS OU from baseline to 49 weeks in the placebo group (0.85 ± 0.19 to 0.85 ± 0.08; p = 0.033) and differences of CS OS at week 49 between treatment groups ( p = 0.046).